Jump to content
 







Main menu
    


Navigation  


●Main page
 ●Contents
 ●Current events
 ●Random article
 ●About Wikipedia
 ●Contact us
 ●Donate
  



Contribute  


●Help
 ●Learn to edit
 ●Community portal
 ●Recent changes
 ●Upload file
  







Search  

































●Create account

●Log in
 









●Create account
 ● Log in
  



Pages for logged out editors learn more  


●Contributions
 ●Talk
  


















Contents

   



(Top)
  


1 References  













GX-19






●العربية
 ●বাংলা
 ●한국어
  
Edit links
  








●Article
 ●Talk
  
















●Read
 ●Edit
 ●View history
  







Tools
    


Actions  


●Read
 ●Edit
 ●View history
  



General  


●What links here
 ●Related changes
 ●Upload file
 ●Special pages
 ●Permanent link
 ●Page information
 ●Cite this page
 ●Get shortened URL
 ●Download QR code
 ●Wikidata item
  



Print/export  


●Download as PDF
 ●Printable version
  















Appearance
    

 





From Wikipedia, the free encyclopedia
  

GX-19
Vaccine description
TargetSARS-CoV-2
Vaccine typeDNA
Clinical data
Other namesGX-19N
Routes of
administration		Intramuscular
Identifiers
DrugBank
Part of a series on the
COVID-19 pandemic
Scientifically accurate atomic model of the external structure of SARS-CoV-2. Each "ball" is an atom.
Scientifically accurate atomic model of the external structure of SARS-CoV-2. Each "ball" is an atom.
Timeline
2019
2020
2021
2022
2023
Locations
By country and territory
By conveyance
International response
  • Evacuations
  • Face masks
  • International aid
  • Origin
  • Lockdowns
  • Misinformation
  • Social distancing
  • Software
  • Travel
  • United Nations
  • WTO IP waiver
  • Undercounting of deaths
  • COVID-19 apps
  • Zero-COVID
    • National responses
    Medical response
  • Development
  • Drug development
  • Drug repurposing
  • Public health mitigation
    • Vaccines
    Current vaccines
    Variants
    Variants of concern
    Other variants
    Economic impact and recession
  • Aviation
  • Cannabis
  • Cinema
  • Disney
  • Fashion
  • Financial markets
  • Food industry
  • Food security
  • Journalism
  • Music
  • Performing arts
  • Retail
  • Shipping
  • Television
  • Tourism
  • Video games
    • By country
    By sport
    Impacts
  • Alzheimer's disease patients
  • Black people
  • Crime
  • Death rates by country
  • Disability
  • Domestic violence
  • Emergency evacuations
  • Education
  • Environment
  • Hospitals
  • Language
  • LGBT community
  • Long-term care
  • Media coverage
  • Mental health
  • Migration
  • Military
  • Notable deaths
  • Other health issues
  • Politics
  • Popular culture
  • Protests
  • Pregnancy
  • Prisons
  • Religion
  • Science and technology
  • Social media
  • Strikes
  • Suicides
  • Telehealth
  • Xenophobia and racism
    • Society
    virus icon COVID-19 portal
  • t
  • e

    • GX-19 is a COVID-19 vaccine candidate developed by Genexine consortium.[1][2][3][4]

    It is a DNA-based vaccine that encodes the SARS-CoV-2 spike protein.[5]

    References[edit]

    1. ^ "Safety and Immunogenicity Study of GX-19, a COVID-19 Preventive DNA Vaccine in Healthy Adults". ClinicalTrials.gov. United States National Library of Medicine. 24 June 2020. NCT04445389. Archived from the original on 11 October 2020. Retrieved 14 July 2020.
  • ^ "Safety and Immunogenicity Study of GX-19N, a COVID-19 Preventive DNA Vaccine in Healthy Adults". clinicaltrials.gov. United States National Library of Medicine. 18 January 2021. Retrieved 16 March 2021.
  • ^ "S. Korea's Genexine begins human trial of coronavirus vaccine". Reuters. 19 June 2020. Archived from the original on 11 October 2020. Retrieved 25 June 2020.
  • ^ "Genexine consortium's Covid-19 vaccine acquires approval for clinical trails in Korea". 11 June 2020. Retrieved 1 August 2020.
  • ^ Seo YB, Suh YS, Ryu JI, Jang H, Oh H, Koo BS, et al. (March 2021). "Soluble Spike DNA Vaccine Provides Long-Term Protective Immunity against SARS-CoV-2 in Mice and Nonhuman Primates". Vaccines. 9 (4): 307. doi:10.3390/vaccines9040307. PMC 8063950. PMID 33804981.
    • Scholia has a profile for GX-19 (Q106616276).
  • icon Viruses
  • virus icon COVID-19
    • Stub icon

    This article about COVID-19 vaccines is a stub. You can help Wikipedia by expanding it.

  • t
  • e
    • Stub icon

    This article about vaccinesorvaccination is a stub. You can help Wikipedia by expanding it.

  • t
  • e

    • Retrieved from "https://en.wikipedia.org/w/index.php?title=GX-19&oldid=1177361641"
    Categories: 
    ●Clinical trials related to COVID-19
     ●South Korean COVID-19 vaccines
     ●DNA vaccines
     ●Science and technology in South Korea
     ●COVID-19 vaccine stubs
     ●Vaccine stubs
     Hidden categories: 
    ●Articles with short description
     ●Short description matches Wikidata
     ●Use dmy dates from April 2021
     ●Chemical articles without CAS registry number
     ●Articles without EBI source
     ●Chemical pages without ChemSpiderID
     ●Articles without KEGG source
     ●Articles without InChI source
     ●Articles without UNII source
     ●Drugs missing an ATC code
     ●Drugs with no legal status
     ●Articles containing unverified chemical infoboxes
     ●Drugs that are a vaccine
     ●All stub articles
      


    ●This page was last edited on 27 September 2023, at 08:53 (UTC).
    ●Text is available under the Creative Commons Attribution-ShareAlike License 4.0; additional terms may apply. By using this site, you agree to the Terms of Use and Privacy Policy. Wikipedia® is a registered trademark of the Wikimedia Foundation, Inc., a non-profit organization.


    ●Privacy policy
    ●About Wikipedia
    ●Disclaimers
    ●Contact Wikipedia
    ●Code of Conduct
    ●Developers
    ●Statistics
    ●Cookie statement
    ●Mobile view


    Wikimedia Foundation
    Powered by MediaWiki